Initiator Pharma
6.6
SEK
-2.94 %
Less than 1K followers
INIT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-2.94%
-7.69%
-3.65%
-5.04%
-11.41%
-27.47%
-18.52%
+43.67%
+47.13%
Initiator Pharma is a biotechnology company. Today, the main focus is to develop drug candidates to be used in treatment of erectile dysfunction in men. The company currently has pharmaceuticals in clinical stage testing for patients that do not respond on PDE5i pharmaceuticals. Initiator Pharma was created as a spin-off from Saniona and is today based in Åbyhøj.
Read moreMarket cap
370.65M SEK
Turnover
582.07K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
9/5
2025
Interim report Q1'25
23/5
2025
General meeting '25
22/8
2025
Interim report Q2'25
All
Press releases
3rd party
ShowingAll content types
Dr. Göran Ando is proposed for election to Initiator Pharma’s Board of Directors and appointed as senior advisor in business development
Carnegie Access: Initiator Pharma: Highlights from Carnegie’s Healthcare Conference
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools